Difference between revisions of "MR Coordinating Committee"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
:Chairs: Michael Boss, PhD (Co-Chair); Caroline Chung, MD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair) | :Chairs: Michael Boss, PhD (Co-Chair); Caroline Chung, MD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair) | ||
:RSNA Staff Support: Susan Stanfa | :RSNA Staff Support: Susan Stanfa | ||
| − | [https:// | + | [https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true Roster] |
Revision as of 16:57, 30 July 2020
- Chairs: Michael Boss, PhD (Co-Chair); Caroline Chung, MD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair)
- RSNA Staff Support: Susan Stanfa
Scope
The MR Coordinating Committee coordinates Biomarker Committees based on MR.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the MR Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact RSNA Staff for details.